{rfName}
AT

Indexed in

License and use

Citations

11

Altmetrics

Analysis of institutional authors

González?enguita CAuthor
Share
Publications
>
Article

ATOMS (Adjustable transobturator male system) is an effective and safe second‐line treatment option for recurrent urinary incontinence after implantation of an advance/advance XP fixed male sling. a multicenter cohort analysis

Publicated to:Journal of Clinical Medicine. 11 (1): - 2022-01-01 11(1), DOI: 10.3390/jcm11010081

Authors: Queissert F; Rourke K; Schönburg S; Giammò A; Gonsior A; González‐enguita C; Romero A; Schrader AJ; Cruz F; Martins FE; Dorado JF; Angulo JC

Affiliations

Alberta Univ, Dept Urol, 116 St & 85 Ave, Edmonton, AB T6G 2R3, Canada - Author
AOU Citta Salute Sci Torino, Spinal Cord Unit, Dept Neurourol, CTO, Via Gianfranco Zuretti 29, I-10126 Turin, Italy - Author
Ctr Hosp Sao Joao, Fac Med Porto, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal - Author
Hosp Univ Fdn Jimenez Diaz, Dept Urol, Av Reyes Catolicos 2, Madrid 28040, Spain - Author
Hosp Univ Morales Meseguer, Dept Urol, Av Marques Velez S-N, Murcia 30008, Spain - Author
I3S Inst, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal - Author
Martin Luther Univ Halle Wittenberg, Dept Urol & Kidney Transplantat, Univ 10, D-06108 Halle, Saale, Germany - Author
PeRTICA Stat Solut, Av Leonardo Da Vinci 8,OF217, Madrid 28906, Spain - Author
Univ Europea Madrid, Fac BioMed Sci, Clin Dept, Carretera Toledo,Km 12-500, Madrid 28905, Spain - Author
Univ Leipzig, Klin & Pol Urol, Augustuspl 10, D-04109 Leipzig, Germany - Author
Univ Lisboa Norte, Ctr Hosp, Hosp Santa Maria, Av Prof Egas Moniz MB, P-1649028 Lisbon, Portugal - Author
Univ Munster, Dept Urol & Pediat Urol, Schlosspl 2, D-48149 Munster, Germany - Author
See more

Abstract

(1) Background: This study examined outcomes of second‐line ATOMS implantation after failure of the fixed male sling (FMS) AdVance/AdVance XP. (2) Methods: A retrospective multicenter cohort analysis was carried out in men implanted with an ATOMS between 2011 and 2020 after failure of an AdVance/AdVance XP. Success was assessed on the basis of objective (dryness, 0–1 pad/24 h or >20 g/24 h pad test) and subjective results (PGI‐I). We performed the Wilcoxon rank sum test, Fisher’s exact test, logistic regression, and multivariate analysis. (3) Results: The study included 88 patients from 9 centers with a mean age of 71.3 years. No Clavien–Dindo > II complications occurred within the first 3 months after ATOMS implantation. A total of 10 cases (9%) required revision in the ensuing clinical course. After a mean follow‐up of 42.5 months, 76.1% achieved social continence, and 56.8% used no pads at all. Mean urine leakage/24 h dropped from 422 g (3.9 pads) to 38 g (0.69 pads) and the mean ICIQ‐SF decreased from 16.25 to 5.3 (p < 0.0001). PROMs (patient‐reported outcome measures) showed improvement in 98.9% of cases, and 63.6% gave a “very much better” PGI‐I rating. Multivariate analysis identified a lower probability of achieving maximum satisfaction for the following factors: the AdVance XP as first‐line therapy (OR 0.35), a lower ICIQ‐SF question 1 (OR 0.26), status post‐irradiation (OR 0.14), and more severe pain prior to ATOMS implantation (OR 0.51). (4) Conclusions: Implantation of an ATOMS is an effective and safe second‐line treatment option for recurrent urinary incontinence after implantation of an AdVance/AdVance XP sling. High patient satisfaction was demonstrated in a long‐term follow‐up.

Keywords
adjustable transobturator male systemartificial urinary sphincterfailurefixed male slingsling failurestress urinary incontinenceAdjustable transobturator male systemArtificial urinary sphincterFixed male slingSling failureSphincterStress urinary incontinence

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal of Clinical Medicine due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Medicine (Miscellaneous).

From a relative perspective, and based on the normalized impact indicator calculated from World Citations from Scopus Elsevier, it yields a value for the Field-Weighted Citation Impact from the Scopus agency: 1.14, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 2.3 (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-08, the following number of citations:

  • WoS: 3
  • Scopus: 5
  • Europe PMC: 3
  • OpenCitations: 5
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-08:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 14.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 14 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.25.
  • The number of mentions on the social network Facebook: 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Canada; Germany; Italy; Portugal.